Pembrolizumab, sold under the brand name Keytruda, is a humanized antibody, more specifically a PD-1 inhibitor, used in cancer immunotherapy that treats melanoma, lung cancer, head and …

Jun 16, 2016 · Pembrolizumab is a type of immunotherapy used to treat cancers, including lung cancer, breast cancer, melanoma, head and neck cancer, and many more. Pembrolizumab …

Learn about KEYTRUDA® (pembrolizumab), an immunotherapy that works with your immune system to help fight certain cancers. Visit the patient website.

Jun 26, 2023 · Pembrolizumab is a humanized monoclonal IgG4 kappa antibody directed against human cell surface PD-1 (programmed death receptor-1) on lymphocytes. The PD-1 receptor …

Pembrolizumab is a type of immunotherapy drug called an immune checkpoint inhibitor. FDA label information for this drug is available at DailyMed. Pembrolizumab is approved to treat: Biliary …

May 1, 2025 · Pembrolizumab injection is used alone to treat non-small cell lung cancer (NSCLC) that has spread, whose tumors express PD-L1 and do not have an abnormal EGFR or ALK …

Dec 18, 2024 · Overview: Keytruda is used to treat many types of cancer. The medicine helps to turn on the body's immune system, so it can attack cancer cells. Common side effects of …

Jun 21, 2024 · Pembrolizumab is a monoclonal antibody used to treat patients with unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRAF V600 …

Jun 13, 2025 · Pembrolizumab should be administered prior to chemotherapy when given on the same day. Expedited Programs. This review was conducted under Project Orbis, an initiative …

Pembrolizumab is a type of targeted therapy that does not directly kill cancer cells but alters a specific cell mechanism that promotes cancer growth and spread. Pembrolizumab works by …